Early antiretroviral therapy and mortality among HIV-infected infants

Date
2008
Authors
Violari A.
Cotton M.F.
Gibb D.M.
Babiker A.G.
Steyn J.
Madhi S.A.
Jean-Philippe P.
McIntyre J.A.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
Keywords
abacavir, didanosine, efavirenz, lamivudine, lopinavir plus ritonavir, nevirapine, stavudine, zidovudine, anemia, article, bacterial infection, CD4+ T lymphocyte, chronic lung disease, clinical trial, controlled clinical trial, controlled study, cytomegalovirus infection, disease course, drug dose regimen, drug safety, drug substitution, drug treatment failure, drug withdrawal, esophagus candidiasis, extrapulmonary tuberculosis, female, gastroenteritis, highly active antiretroviral therapy, human, Human immunodeficiency virus infection, hyperkalemia, hypernatremia, hypokalemia, hyponatremia, infant, interstitial pneumonia, major clinical study, male, meningitis, mortality, neutropenia, phase 3 clinical trial, Pneumocystis pneumonia, pneumonia, priority journal, randomized controlled trial, side effect, thrombocytopenia, treatment duration, treatment outcome, tuberculosis, virus transmission, wasting syndrome, Anti-HIV Agents, CD4 Lymphocyte Count, Disease Progression, Drug Administration Schedule, Drug Therapy, Combination, Female, Follow-Up Studies, HIV Infections, HIV-1, Humans, Infant, Infectious Disease Transmission, Vertical, Lamivudine, Male, Pyrimidinones, Ritonavir, Treatment Failure, Zidovudine
Citation
New England Journal of Medicine
359
21
http://www.scopus.com/inward/record.url?eid=2-s2.0-56749097184&partnerID=40&md5=771f5001a2360d51069d3b21f73e12e4